SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Astria Therapeutics, Inc. ATXS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Astria Therapeutics, Inc. (ATXS) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRV, ADAG, ANAB, ANEB, ANTX, AVTE and others.

ATXS has a market capitalization of $718.13M, compared to an average peer market cap of $764.53M.

Peers & Similar Companies — ATXS

Acrivon Therapeutics, Inc. Common Stock

$1.64 +1.86% $51.75M

$3.81 -0.78% $143.44M

AnaptysBio, Inc.

$70.22 +2.17% $2.02B

Anebulo Pharmaceuticals, Inc.

$0.50 -0.04% $20.39M

AN2 Therapeutics, Inc.

$2.98 -1.00% $81.66M

Aerovate Therapeutics, Inc.

$2.68 0.00% $77.68M

Fennec Pharmaceuticals Inc.

$6.25 +5.40% $178.63M

Disc Medicine, Inc.

$70.48 +2.95% $2.69B

Larimar Therapeutics, Inc.

$4.87 +0.21% $416.77M

Mineralys Therapeutics, Inc.

$27.32 +0.59% $1.81B

Orchestra BioMed Holdings, Inc.

$4.51 +4.88% $263.93M

Olema Pharmaceuticals, Inc.

$16.30 +2.32% $1.42B

People Also View

Disc Medicine, Inc.

AnaptysBio, Inc.

Mineralys Therapeutics, Inc.

Olema Pharmaceuticals, Inc.

Larimar Therapeutics, Inc.

Orchestra BioMed Holdings, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message